Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -18.51%25.77B | -0.60%116.42B | 2.39%31.63B | -0.01%117.13B | -2.75%30.48B | -4.95%29.09B | -1.85%26.67B | 10.24%30.89B | 12.14%117.14B | 7.13%31.35B |
| Cost of revenue | -12.19%24.09B | 0.32%103.37B | 4.00%27.43B | -1.53%103.04B | -5.54%26.77B | -9.37%25.8B | 3.54%24.1B | 7.39%26.37B | 11.12%104.64B | 3.80%28.34B |
| Gross profit | -59.85%1.69B | -7.35%13.05B | -7.02%4.2B | 12.67%14.09B | 23.61%3.71B | 53.76%3.29B | -34.09%2.57B | 30.50%4.51B | 21.51%12.5B | 53.76%3B |
| Operating expense | 5.67%2.18B | 8.63%7.81B | 16.82%2.06B | 7.83%7.19B | 3.35%1.85B | 10.13%1.81B | 5.88%1.76B | 12.63%1.77B | 2.46%6.66B | 12.64%1.79B |
| Staff costs | 13.68%374M | 5.86%1.39B | 1.54%329M | 5.38%1.31B | 10.22%345M | -0.95%312M | 5.40%332M | 6.93%324M | 3.23%1.25B | 1.62%313M |
| Selling and administrative expenses | -17.85%856M | 6.49%3.63B | 19.09%1.04B | 8.24%3.4B | 1.06%859M | 4.27%831M | 9.10%839M | 20.03%875M | -0.32%3.15B | 9.25%850M |
| -Selling and marketing expense | -17.85%856M | 6.49%3.63B | 19.09%1.04B | 8.24%3.4B | 1.06%859M | 4.27%831M | 9.10%839M | 20.03%875M | -0.32%3.15B | 9.25%850M |
| Depreciation and amortization | -10.53%17M | 0.00%73M | 11.76%19M | 0.00%73M | 0.00%19M | -10.00%18M | 5.56%19M | 6.25%17M | -16.09%73M | -5.00%19M |
| -Depreciation | -10.53%17M | 0.00%73M | 11.76%19M | 0.00%73M | 0.00%19M | -10.00%18M | 5.56%19M | 6.25%17M | -16.09%73M | -5.00%19M |
| Other operating expenses | 38.63%933M | 13.44%2.72B | 22.36%673M | 8.91%2.4B | 3.12%628M | 27.02%644M | 1.77%574M | 5.77%550M | 7.06%2.2B | 25.83%609M |
| Operating profit | -123.20%-495M | -23.98%5.25B | -22.34%2.13B | 18.19%6.9B | 53.55%1.86B | 196.80%1.48B | -63.86%808M | 45.32%2.75B | 54.23%5.84B | 233.88%1.21B |
| Net non-operating interest income (expenses) | -33.33%-16M | 99.33%-6M | 93.10%-12M | -172.70%-889M | -60.81%-238M | -184.54%-276M | -229.51%-201M | -770.00%-174M | -401.54%-326M | -448.15%-148M |
| Non-operating interest income | 3.23%64M | 81.25%319M | 58.97%62M | 12.82%176M | 51.35%56M | 10.53%42M | -2.50%39M | -4.88%39M | -7.69%156M | -7.50%37M |
| Non-operating interest expense | 8.11%80M | -69.48%325M | -65.26%74M | 120.95%1.07B | 58.92%294M | 135.56%318M | 137.62%240M | 249.18%213M | 105.98%482M | 176.12%185M |
| Net investment income | -196.91%-1.13B | -173.47%-108M | 317.92%1.17B | 133.11%147M | 163.64%77M | -184.62%-185M | 89.19%-24M | 875.00%279M | -326.92%-444M | -2,520.00%-121M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -117.90%-29M | -127.82%-303M | 162M | -113.05%-133M | -242.99%-367M | -37.18%223M | -95.70%11M | 0 | 1.02B | -107M |
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 1,850.00%39M | -98.00%2M | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -26.67%-38M | 115.23%113M | 18.92%-30M | 50.43%-742M | -988.89%-80M | -1,302.38%-589M | 55.56%-36M | 97.32%-37M | -513.52%-1.5B | 107.96%9M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | ---- | -66.25%458M | --0 | ---- | ---- | --0 | --1.36B | ---54M |
| Less:Other special charges | 26.67%38M | -139.79%-113M | -18.92%30M | 102.86%284M | 77.78%80M | 211.90%131M | --36M | --37M | -42.62%140M | -60.18%45M |
| Other non-operating income (expenses) | 15.60%126M | -3.10%407M | 49.32%109M | -3.45%420M | 128.74%199M | -71.17%32M | 0.87%116M | -40.16%73M | 2.11%435M | 611.76%87M |
| Income before tax | -144.98%-1.59B | -6.90%5.35B | 22.09%3.53B | 14.20%5.74B | 59.57%1.49B | -9.84%687M | -69.95%674M | 165.69%2.89B | 29.03%5.03B | 198.72%935M |
| Income tax | -109.18%-107M | -17.05%2.08B | 43.77%1.17B | 4.06%2.51B | 15.21%674M | -33.64%501M | -34.62%525M | 200.37%811M | 98.11%2.41B | 261.11%585M |
| Net income | -162.70%-1.48B | 0.99%3.26B | 13.58%2.36B | 23.53%3.23B | 132.76%817M | 2,571.43%187M | -89.72%148M | 154.22%2.08B | -2.35%2.61B | 134.00%351M |
| Net income continuous operations | -162.67%-1.48B | 0.99%3.26B | 13.63%2.36B | 23.57%3.23B | 133.71%818M | 2,557.14%186M | -89.65%149M | 154.22%2.08B | -2.39%2.61B | 131.79%350M |
| Noncontrolling interests | -85.71%6M | -69.44%33M | -32.26%42M | 137.37%108M | 344.66%252M | 60.52%-92M | -385.00%-114M | 785.71%62M | -362.73%-289M | -590.48%-103M |
| Net income attributable to the company | -164.09%-1.49B | 3.40%3.23B | 15.04%2.32B | 7.51%3.12B | 24.45%565M | 15.35%278M | -81.12%264M | 148.64%2.01B | 13.09%2.9B | 251.94%454M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -164.09%-1.49B | 3.40%3.23B | 15.04%2.32B | 7.51%3.12B | 24.45%565M | 15.35%278M | -81.12%264M | 148.64%2.01B | 13.09%2.9B | 251.94%454M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -183.39%-49.66 | 3.40%82.94 | 15.03%59.55 | 7.52%80.21 | 24.64%14.52 | 15.30%7.16 | -81.18%6.76 | 148.66%51.77 | 13.10%74.6 | 250.90%11.65 |
| Diluted earnings per share | -183.39%-49.66 | 3.40%82.94 | 15.03%59.55 | 7.52%80.21 | 24.61%14.5172 | 15.35%7.1429 | -81.18%6.76 | 148.66%51.77 | 13.10%74.6 | 251.49%11.65 |
| Dividend per share | 0 | 38.78%34 | 0 | 8.89%24.5 | 0.00%14.5 | 0 | 25.00%10 | 0 | 9.76%22.5 | 7.41%14.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |